EDWARD J. RAPP - 09 May 2025 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
/s/ T.O. Odutayo, attorney-in-fact for Edward J. Rapp
Issuer symbol
ABBV
Transactions as of
09 May 2025
Net transactions value
$0
Form type
4
Filing time
13 May 2025, 17:05:04 UTC
Previous filing
30 Apr 2025
Next filing
02 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
RAPP EDWARD J Director 1 N. WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, attorney-in-fact for Edward J. Rapp 13 May 2025 0001171780

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Award $0 +1,203 +3.6% $0.000000 34,458 09 May 2025 Direct F1, F2
holding ABBV Common Stock, $0.01 par value 10,388 09 May 2025 By spouse in trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2 Includes an additional 1,899 shares which, due to an administrative error, were inadvertently omitted from a previously filed form.
F3 The reporting person disclaims beneficial ownership of all securities held by his wife.